Cystic Fibrosis
Rare Disease·MeSH: Cystic Fibrosis
Prevalence
4.0 / 100K
Incidence
3.5 / 100K/yr
60 drugs in development·26 companies·38 clinical trials
Drug Pipeline by Phase
Approved(8)
Phase 3(2)
Phase 2(26)
Phase 1(14)
Preclinical(3)
Unknown(1)
| Drug | Company |
|---|---|
| acg-701 | Aceragen, Inc. (ACGN) |
Phase 1/Phase 2(5)
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Cystic Fibrosis?
BioSniper tracks 60 drugs in development for Cystic Fibrosis across 26 companies.
How many clinical trials target Cystic Fibrosis?
There are 38 clinical trials targeting Cystic Fibrosis tracked by BioSniper.
What is the prevalence of Cystic Fibrosis?
The estimated prevalence of Cystic Fibrosis is approximately 4.0 per 100,000 population.
Deep-dive into Cystic Fibrosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis